GeneCellNano
GeneCellNano Flagship develops new biological drugs, so-called ATMP products, biomarkers and diagnostics for diseases with unmet clinical need. New treatments are developed for cardiovascular diseases and age-related macular degeneration, as well as for brain, ovarian and bladder cancer.
Project information
Project duration
-
Project coordinator
Other university or unit
Unit and faculty
Contact information
Researchers
Project description
From the University of Oulu, our investigators are professors Seppo Vainio, Peppi Karppinen, and Lauri Eklund.
Please visit the GeneCellNano website at www.genecellnano.fi.